Login
$MITQ
$0.52 +$0.00 (0.0%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2026
As of Jun 30, 2026
Q3 FY2026
As of Mar 31, 2026
Q2 FY2026
As of Dec 31, 2025
Q1 FY2026
As of Sep 30, 2025
Q4 FY2025
As of Jun 30, 2025
Q3 FY2025
As of Mar 31, 2025
Q2 FY2025
As of Dec 31, 2024
Q1 FY2025
As of Sep 30, 2024
Q4 FY2024
As of Jun 30, 2024
Q3 FY2024
As of Mar 31, 2024
Q2 FY2024
As of Dec 31, 2023
Q1 FY2024
As of Sep 30, 2023
Q4 FY2023
As of Jun 30, 2023
Q3 FY2023
As of Mar 31, 2023
Q2 FY2023
As of Dec 31, 2022
Q1 FY2023
As of Sep 30, 2022
Q4 FY2022
As of Jun 30, 2022
Q3 FY2022
As of Mar 31, 2022
Q2 FY2022
As of Dec 31, 2021
Q1 FY2022
As of Sep 30, 2021
Current Assets:
Cash
Accounts receivable, net
Inventories, net
Prepaid expenses and other
Total Current Assets
Long-Term Assets:
Right-of-use asset
Property and equipment, net
Goodwill
Intangibles, net
Other assets
Total Long-Term Assets
Total Assets
Current Liabilities:
Accounts payable
Accrued expenses
Customer refunds
Customer deposits
Lease liability–current
Unearned warranty revenue
Total Current Liabilities
Long-Term Liabilities:
Lease liability–non-current
Total Long-Term Liabilities
Total Liabilities
Stockholders’ Equity
Common stock, $0.00001 par value, 100,000,000 shares authorized, 9,952,223 and 9,939,080 shares issued and outstanding at June 30, 2026 and June 30, 2025, respectively
Additional paid-in capital
Accumulated deficit
Total Stockholders’ Equity
Total Liabilities and Stockholders’ Equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support